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REVIEW
Effect of propofol and remifentanil 
on cerebral perfusion and oxygenation in pigs:  
a systematic review
Mai Louise Grandsgaard Mikkelsen1*, Rikard Ambrus2, James Edward Miles1, Helle Harding Poulsen1, 
Finn Borgbjerg Moltke3,4 and Thomas Eriksen1
Abstract 
The objective of this review is to evaluate the existing literature with regard to the influence of propofol and remifen-
tanil total intravenous anaesthesia (TIVA) on cerebral perfusion and oxygenation in healthy pigs. Anaesthesia has influ-
ence on cerebral haemodynamics and it is important not only in human but also in veterinary anaesthesia to preserve 
optimal regulation of cerebral haemodynamics. Propofol and remifentanil are widely used in neuroanaesthesia and 
are increasingly used in experimental animal studies. In translational models, the pig has advantages compared to 
small laboratory animals because of brain anatomy, metabolism, neurophysiological maturation, and cerebral haemo-
dynamics. However, reported effects of propofol and remifentanil on cerebral perfusion and oxygenation in pigs 
have not been reviewed. An electronic search identified 99 articles in English. Title and abstract screening selected 
29 articles for full-text evaluation of which 19 were excluded with reasons. Of the 10 peer-reviewed articles included 
for review, only three had propofol or remifentanil anaesthesia as the primary study objective and only two directly 
investigated the effect of anaesthesia on cerebral perfusion and oxygenation (CPO). The evidence evaluated in this 
systematic review is limited, not focused on propofol and remifentanil and possibly influenced by factors of potential 
importance for CPO assessment. In one study of healthy pigs, CPO measures were within normal ranges following 
propofol-remifentanil anaesthesia, and addition of a single remifentanil bolus did not affect regional cerebral oxygen 
saturation (rSO2). Even though the pool of evidence suggests that propofol and remifentanil alone or in combination 
have limited effects on CPO in healthy pigs, confirmative evidence is lacking.
Keywords: Animal model, Brain, Oxygenation, Perfusion, Pig, Propofol, Remifentanil, Neuroanaesthesia
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Preservation of optimal cerebral perfusion and oxygena-
tion (CPO) is the primary concern in assessing neuro-
critical patients undergoing surgery or sedation in the 
intensive care unit or for diagnostic procedures, and is 
equally important in both human and veterinary anaes-
thesia [1, 2]. Animal models have been used increasingly 
over the last decade to study the significance of influen-
tial factors on cerebral haemodynamics and to achieve 
better understanding of mechanisms regulating CPO. 
Rodents and primates are widely used in neuroscience 
but recently the interest for use of pigs in neuroscience 
has increased. The pig is readily available through com-
mercial sources and the gyrencephalic porcine brain 
resembles the human brain in several areas of gross anat-
omy, growth, and development [3]. The pig brain shows 
similarities in gyral pattern, distribution of grey and 
white matter, cerebral blood flow, and metabolism to the 
human brain. In addition, similarities in neurophysiologi-
cal development and post-natal maturation with human 
brains are of value in human neuro-embryology and pae-
diatric neuro-science [3–5]. Various porcine models have 
been described with the objective of CPO evaluation, but 
mostly they have been developed in the context of neuro-
logical trauma or diseases, such as traumatic brain injury 
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[6, 7], subdural haematoma [8], intracranial hypertension 
[9, 10], as well as epilepsy [11] and stroke [12].
Cerebral perfusion and cerebral oxygenation are 
two separate measures that are often used simultane-
ously and sometimes interchangeably as clinical assess-
ment measures to evaluate the physiological status of 
the brain. Both measures are used to assess the risk of 
ischemic brain damage and thus to predict clinical out-
come and prognosis of the patient. The cerebral perfu-
sion is often clinically assessed by evaluation of changes 
in the cerebral blood flow (CBF). Cerebral blood flow 
is controlled by homeostatic regulation of the cerebral 
perfusion pressure (CPP) and cerebral vascular resist-
ance (CVR). Mean arterial blood pressure (MAP) and 
the intracranial pressure (ICP) are determinants of CPP 
giving CPP  =  MAP−ICP, and CBF may therefore be 
assumed as CBF  =  MAP−ICP/CVR [13–16]. Overall, 
several physiological or pathological conditions there-
fore may influence cerebral perfusion. Physiological 
alterations in blood pressure, cerebral metabolic rate, 
temperature, arterial carbon dioxide or oxygen con-
tents, blood viscosity and pathological conditions such 
as hypertension, vascular disease, trauma or seizures all 
may influence perfusion [2, 13–16]. Mean arterial pres-
sure can under normal conditions, and for patients in 
supine position, adequately represent the CPP for evalu-
ation of CBF [16]. Clinically, CPP is used as an indirect 
index for CBF [17]. The maintenance of constant and 
stable CBF is essential for optimal cerebral metabo-
lism and function, and is under normal physiological 
conditions secured by intrinsic cerebral autoregulatory 
mechanisms [16]. Cerebral autoregulation is the haemo-
dynamic ability of the cerebral vasculature to maintain 
a constant CBF despite changes in blood pressure and 
consequently changes in MAP [18]. The limit of this pre-
servative regulatory mechanism is generally observed in 
the MAP range of 50–150 mmHg. When MAP is above 
or below these values, CBF varies markedly with MAP, 
because the ability of the individual vessels to change in 
diameter has been exhausted [19].
Cerebral oxygenation represents a measure for the 
amount of oxygen actually available for consumption 
and energy metabolism in the cerebral tissue, and can 
be defined as either the brain tissue partial pressure of 
oxygen (brPO2) [20], or as regional cerebral oxygen sat-
uration (rSO2) [21]. Venous jugular oxygen saturation 
(SvjO2) normally provides an indirect measure for cer-
ebral oxygen utilization, and thereby gives a qualitative 
assessment of CBF, but it is also used as a measure for 
global cerebral oxygen saturation. These parameters rep-
resent the oxygen content available within the tissue or in 
the vascular circuit, and are therefore dependent on CBF 
[1, 14, 22, 23].
Different methods and technologies have been estab-
lished for the quantification and evaluation of cerebral 
haemodynamics, but no gold standard method has been 
fully validated to date, which makes comparison between 
the results of different studies challenging [1, 24, 25]. His-
torically, CBF has been studied by technically advanced 
methods like the nitrous oxide method [26], the krypton 
uptake method [27] or xenon 133 injection method [28, 
29], but can be evaluated by modern techniques such 
as transcranial Doppler ultrasonography, laser Doppler 
flowmetry (LDF), positron emission tomography scan-
ning, functional magnetic resonance imaging [14, 15, 20] 
or laser speckle contrast imaging [30, 31].
Target ranges for cerebral monitoring have been 
defined for healthy humans (Table  1), but are less well 
defined for pigs, which should be considered when 
assessing CPO in porcine models. CBF in pigs has been 
reported to decrease with age, being approximately 48, 44 
and 27 ml/min/100 g in newborn, juvenile and adult pigs 
respectively [32], and thus may be comparable to the val-
ues identified in humans (Table 1).
Normal target values for SvjO2 during anaesthesia have 
not been defined in pigs but Mutch et  al. [33] and two 
studies included in this review reported mean values 
between 74.3 and 82.7  % (Table  6), and CPP has been 
found to vary with anaesthesia [34]. For brPO2, normal 
values in pigs have been found to be 25–30 mm Hg [35], 
which is similar to the range defined in humans (Table 1). 
Regional cerebral oxygen saturation measured by near 
infrared spectroscopy (NIRS) is simple, continuous and 
non-invasive and widely used in human neuroanaesthe-
sia. Thus, it has been suggested that NIRS has potential 
as a central modality in the cerebral monitoring strat-
egy [21]. NIRS has also been investigated in pigs and a 
Table 1 Target ranges for  anaesthesia related cerebral 
perfusion and oxygenation measures in humans
MAP: mean arterial pressure; ICP: intracranial pressure; CPP: cerebral perfusion 
pressure; rSO2: regional cerebral oxygen saturation; SvjO2: jugular venous oxygen 
saturation; brPO2: brain tissue partial pressure of oxygen; CBF: cerebral blood 
flow; CarotidBF: carotid blood flow
a Upper and lower limits for cerebral autoregulation—highest in newborn 
lowest in adults
Target Measure Limits Reference
CerAutoRega mm Hg 50–150 [18]
MAP mm Hg >80 [18, 93]
CPP mm Hg 50–70 [14, 17]
rSO2 % 60–80 [22, 90]
SvjO2 % 50–75 [15, 22]
brPO2 mm Hg 25–50 [17, 90]
CBF ml/min/100 g 25–50 [94]
CarotidBF ml/min 275 ± 52 [95]
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normal value of 65  %, has been suggested [36], ranging 
from 57 to 72  %. In piglets, an ischaemic threshold of 
35 % has also been suggested [37].
Most studies investigating CPO in porcine models are 
carried out in anaesthetized animals. General anaesthesia 
aims at depressing consciousness and cerebral activity. 
General anaesthesia influences systemic cardiovascular 
function and consequently will affect CPO. However, 
when properly monitored and managed, general anaes-
thesia should not alter CPO significantly in the healthy 
brain [38, 39]. The choice of anaesthesia should be evalu-
ated when assessing studies evaluating CPO. Considera-
tion should be given both to the isolated effect of single 
anaesthetic drugs, drug combinations as well as systemic 
physiologic status [39].
Inhalation anaesthesia elicits a dose-related suppres-
sive effect of cerebral metabolism, but also has a direct 
dilating effect on the cerebral vessels that potentially will 
increase CBF. The net effect on CBF will be determined 
by dominating force of these competing and oppos-
ing effects [14, 40]. The general assumption is that most 
intravenous anaesthetic drugs will cause an indirect and 
dose-dependent decrease in CBF by decreasing cerebral 
metabolism [18, 41–44]. Only ketamine seems to be an 
exception to this, by expressing the opposite effect on 
cerebral metabolism, and thereby increasing CBF [43, 
45]. Opioids in general are believed to have minimal 
effect on CBF in clinical doses, but their effect on cere-
bral haemodynamics may vary depending on patient sta-
tus and anaesthetic drugs used [14].
The choice between inhalation and intravenous anaes-
thesia in neurosurgery is debated and even though no 
single anaesthetic drug or regimen appears absolutely 
superior to others [39], an increasing tendency to use 
intravenous protocols as the basic regimen for neurosur-
gical anaesthesia, has been reported [46–49]. Significant 
differences in baseline measurement of MAP and CPP 
between inhalation anaesthesia and total intravenous 
anaesthesia (TIVA) in piglets have been reported, but 
no differences in CBF or PbrO2 were however evident 
between the anaesthesia regimens [34].
Total intravenous anaesthesia (TIVA) with a combi-
nation of propofol and remifentanil is an anaesthetic 
regimen that is widely used in neuroanaesthesia, and has 
advantages over inhalation anaesthesia (sevoflurane and 
isoflurane) with regard to desirable traits like fast recov-
ery, a low incidence of nausea and vomiting, anticonvul-
sive potential, preservation of cerebral autoregulation 
and neuroprotection [40, 49–51]. Propofol is the most 
widely used intravenous anaesthetic agent in both human 
and veterinary medicine [49, 52–54]. Due to its global 
depressant properties in the central nervous system, it 
acts as a very potent hypnotic agent, which can be used 
for both induction and maintenance of general anaesthe-
sia, and for sedation. Its favourable pharmacokinetic pro-
file ensures a fast onset of action and rapid recovery even 
after prolonged administration [55]. Propofol may indi-
rectly reduce CBF mainly due to depression of the sys-
temic blood pressure [53, 55]. The hypotensive effect is 
caused by a decrease in sympathetic activity and intracel-
lular calcium flux resulting in vasodilation [55]. In pigs, 
the vasodilation caused by propofol has also been related 
to release of nitric oxide by the vascular endothelium [55]. 
Propofol has little or no effect on the conductive system 
of the heart and does not cause myocardial depression, 
but inhibits the tachycardiac response to hypotension by 
inhibition of the baroreceptor reflex [53, 55]. The over-
all cerebral effect of propofol has been demonstrated to 
reduce CBF, cerebral metabolic rate of oxygen and intrac-
ranial pressure, but it also acts as an antioxidant and has 
neuroprotective properties [53, 56, 57]. Remifentanil is 
an ultra-short-acting opioid with very potent and selec-
tive µ-receptor agonist activity. It is preferred to fentanyl 
or other opioids due to its non-organ specific metabo-
lism by blood and tissue esterases, which consequently 
results in a faster clearance and thereby faster recovery 
independent of infusion duration [58]. The main cardio-
vascular impact of remifentanil is dominated by moder-
ate bradycardia and a marked decrease in systemic blood 
pressure. The use of remifentanil in humans thus, has an 
increased incidence of hypotensive periods in compari-
son with other opioids [58, 59]. In contrast to this and 
compared to fentanyl-sevoflurane, remifentanil-propofol 
anaesthesia is in human clinical studies also reported to 
increase the incidence of arterial hypertension, hence the 
influence of remifentanil on CPO is somewhat unpre-
dictable and may depend on the anaesthetic agent used 
[59]. In humans low and moderate dose remifentanil 
caused increase in regional CBF while remifentanil in 
high, supra-clinical doses caused a decrease in regional 
CBF [59], and no impairment of the cerebrovascular car-
bon dioxide reactivity [60]. It has been suggested that 
remifentanil in general decreases the cerebral meta-
bolic rate of oxygen and only has minimal effect on intra 
cranial pressure [59, 61] and that the combined use of 
propofol and remifentanil preserves and improves cer-
ebral autoregulation [59]. The overall effects of propofol 
and remifentanil on CBF and cerebral autoregulation 
in selected animal species are summarised in Table  2. 
Since the pig is increasingly of interest as a translational 
model in neurocritical research, it is important to reveal 
whether propofol and remifentanil influence CPO differ-
ently in pigs compared to humans. The objective of this 
review is to evaluate the existing literature with regard to 
the influence of propofol and remifentanil TIVA on cer-
ebral perfusion and oxygenation in healthy pigs.
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Search strategy
On May 10th 2016, an electronic database search was 
made in Agricola 1970 to April 2016, Agris 1975 to 
March 2016, Biosis Previews 1969–2009, CAB Abstracts 
1910–2016 week 17, Embase 1974–2016 May 9th, Inter-
national Pharmaceutical Abstracts 1970–April 2016, 
Zoological Record 1978–2009, Epub ahead of print, In-
process and Other non-indexed citations, MEDLINE 
daily and MEDLINE 1946 to present. The specific terms 
used for the different search components were: (1) cer-
ebral or brain or central nervous system (CNS), (2) CNS, 
(3) 1 OR 2, (4) pig or pigs or piglet or piglets or swine or 
swines or landrace or porcine or minipig or minipigs, (5) 
3 and 4, (6) propofol or remifentanil or TIVA, (7) TIVA, 
(8) TIVA, (9) 6 or 7 or 8, (10) 5 and 9, (11) guinea or guin-
eapig or guineapigs or guinea-pig or guinea-pigs, (12) 10 
not 11. The only filter applied was English, and the ref-
erence lists of relevant articles and recent reviews were 
hand-searched for additional studies. Three authors did 
the screening individually and any disagreement in selec-
tion were settled by mutual agreement.
Studies that evaluated CPO and used propofol or 
remifentanil for TIVA in healthy pigs of all ages and 
breeds were included in the systematic review. This also 
included studies that only indirectly assessed the effect 
of propofol or remifentanil on CPO. Studies where addi-
tional anaesthetic drugs were given for maintenance of 
anaesthesia were excluded. Eligible records (Fig. 1) were 
retrieved in full text and screened for relevant anaesthe-
sia protocols and outcome data.
Data extraction
This systematic review is based on the principles rec-
ommended by the SYRCLE collaboration [62] and 
O´Connors and Sargeant [63]. Primary outcome data rel-
evant to this systematic review were any CPO parameter. 
Secondary outcome data extracted were publication year, 
study type, number of animals, breed, bodyweight, age, 
gender, doses of preanaesthetic and other medications, 
doses of propofol and remifentanil, and MAP.
Synthesis of the CPO-data was made on the basis of 
means, standard deviations and 95 % confidence intervals 
and is discussed with regard to secondary outcome data. 
Standard errors of means were transformed to standard 
deviations. If not reported, animal age was estimated 
based on weight [64–66].
Review
Search results
The electronic search identified 99 articles in english, of 
which 29 were eligible after title and abstract screening. 
Of these, 19 studies were excluded after full text exami-
nation (Fig. 1). Of the10 peer-reviewed articles included 
in this review, only three had propofol or remifentanil 
anaesthesia as the primary study objective, and only two 
investigated the effect of anaesthesia on CPO (Table  3). 
The studies were published between 2001 and 2014, and 
all but one, were non-survival studies. Post-intervention 
data from the survival study were not included in this 
review.
Animals
Data from a total of 133 animals are included in this 
review. All studies used farm pigs. Eight of the studies 
used animals with a bodyweight between 16 and 33 kg, 
while one used animals between 7.5 and 14.5  kg and 
another between 21.5 and 92.8  kg. Seven studies used 
female and three used male pigs: none of the studies used 
both (Table 4).
Anaesthesia
Three studies used a combination of propofol and 
remifentanil, and seven studies used propofol alone 
(Table  3). In all studies, anaesthesia was induced with 
propofol intravenously (iv) (1–4 mg/kg) and maintained 
with propofol (3–15  mg/kg/h). In 3 studies remifenta-
nil was given in a dose range of 0.2–0.35  µg/kg/min. In 
addition to propofol and remifentanil infusion, Silva 
et  al. [67] investigated the effect of a single intravenous 
bolus of 5  µg/kg remifentanil. Intramuscularly (im) 
Table 2 Summary of  the effects of  propofol and  remifentanil on  cerebral blood flow and  cerebral autoregulation 
in selected animal species used in experimental neuroscience
CBF: cerebral blood flow; CA: cerebral autoregulation; P: propofol; R: remifentanil; PR: propofol-remifentanil combination; ↑: increased; ↓: decreased; •: uncertain; *: 
dose dependant
Species CBF CA References
P R PR P PR
Humans ↓ ↑↓* ↓ Preserved Preserved [18, 52, 55, 56, 58]
Dog ↓ ↓ • Preserved • [96, 97]
Rabbit ↓ • • • • [98]
Rat ↓ • • Preserved • [99]
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azaperone 4  mg/kg was used in two studies while keta-
mine, 10–33  mg/kg im, was used for premedication in 
eight of the studies. Six of these studies used ketamine 
alone, one added xylazine and one added xylazine, tile-
tamine and zolazepam. Single bolus pancuronium was 
used for muscle relaxation in one study [68], and flunixin, 
2.2  mg/kg im was used pre-emptively for postoperative 
analgesia in one single survival study [69].
Study design
The included studies were animal intervention studies. 
Four studies used a 1-group design with pre-post-test 
assessment. Six 6 studies used a 2-group design of which 
4 used random sequence allocation. Only Silva et  al. 
[67] studied the effects of propofol-remifentanil anaes-
thesia on CPO as the primary objective. The remaining 
9 studies did not have CPO in relation to anaesthesia as 
their primary objective. However, all were clear in their 
description of objectives and possible factors of influence 
are discussed below.
Extracted data
Predefined respiratory baseline limits were similar 
across studies, with target limits set at a respiratory 
rate of 10–14/min, tidal volume of 10–20  ml/kg, arte-
rial CO2 (PaCO2) or end tidal CO2 (EtCO2) between 35 
and 45  mmHg, arterial oxygen (PaO2) >80  mm  Hg and 
oxygen saturation (SpO2) >90 %. However, not all param-
eters were reported in all studies. Predefined haemody-
namic baseline limits were not reported in detail in any 
of the studies, but Boezaart [68], Navarro et  al. [70], 
Silva et  al. [71] and Srinivasan et  al. [72], reported that 
Records identified through 
database searching
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Records after duplicates removed
(n = 99)
Records screened
(n = 99)
Records excluded
(n = 70)
Full-text articles assessed 
for eligibility
(n = 29)
Full-text articles excluded, 
with reasons
(n = 19)
Maintenance anaesthesia 
other than propofol or 
remifentanil (n = 13)
No relevant CPO outcome 
data (n = 4)
Anaesthesia maintenance 
dose not reported (n = 2)
Studies included in 
qualitative synthesis
(n = 10)
Fig. 1 PRISMA flow chart, Based on [102]
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haemodynamic baseline recordings had to be stable prior 
to intervention. MAP and the 95 % confidence interval of 
all studies were within the limits of cerebral autoregula-
tion (Table 5).
Cerebral blood flow was reported on the basis of 
directly measured transdural flow in tissue perfusion 
units, indirectly measured carotid artery blood flow in 
ml/min or jugular venous oxygen saturation (SvjO2) in  % 
or as cerebral perfusion pressure (CPP) in mm Hg. Mean 
CPP was reported in four studies and ranged from 68 to 
74.8 mm Hg (Table 6).
Cerebral oxygenation was reported on the basis of 
direct measurement of brain tissue partial pressure of 
oxygen (brPO2) in mm Hg or indirect transcranial meas-
urement of regional cerebral oxygen saturation (rSO2) in 
%. Data for brPO2 from one study [73] was not reported 
in absolute values, but were extracted from a graph. Val-
ues for rSO2 between 51 and 65 % were reported in three 
Tabel 3 Anaesthesia relevant data
a Doses are calculated based on animal weight
b Doses reported as mikrogram/kg/min are converted to mg/kg/h for easier comparison
c Calculated under the assumption that lowest dose was given to animals with lowest weight
Study ID [reference] Premedication. drug (dosea) Propofol doseb (induction/maintenance) Remifentanil dose
Boezaart [68] Ketamine (10 mg/kg im)  
Pancuronium (0.1 mg/kg)
2.0 mg/kg/3.0 mg/kg/h 0.35 mikrogram/kg/min
Kajimoto et al. [82] Ketamine (33 mg/kg im)  
xylazine (2 mg/kg im)
1.0–2.0 mg/kg/15.0 mg/kg/h for 15 min then  
12.0/mg/h for 45 min then 9.0 mg/kg/h for  
60 min then 7.5 mg/kg for 120 min
Not used
Lurie et al. [73] Ketamine (21.9–25.0 mg/kg im) 2.3 mg/kg + 1.0 mg/kg/9.6 mg/kg/h Not used
Navarro et al. [70] Ketamine/Telazol/xylazine im (not 
reported)
1.5 mg/kg/9.0 mg/kg/h Not used
Silva et al. [71] Azaperone (4 mg/kg im) 4.0 mg/kg/15.0 mg/kg/h 0.3 mikrogram/kg/min followed  
by 0.2 mikrogram/kg/min
Silva et al. [67] Azaperone (4 mg/kg im) 4.0 mg/kg/15.0 mg/kg/h 0.3 mikrogram/kg/min +  
5 mikrogram/kg bolus
Srinivasan et al. [72] Ketamine (21.2–31.3 mg/kg im)c 2.0–3.0 mg/kg/9.6 mg/kg Not used
Yannopoulos et al. [100] Ketamine (23.0–23.7 mg/kg im) 1.0 mg/kg/9.6 mg/kg/h Not used
Yannopoulos et al. [101] Ketamine (21.7–23.5 mg/kg im) 2.0 mg/kg/9.6 mg/kg/h Not used
Yannopoulos et al. [69] Ketamine (25.6–30.3 mg/kg im) 2.3 mg/kg/9.6 mg/kg/h Not used
Tabel 4 Animal and publication relevant data
n: number of animals; NA: not applicable
a Mean ± SD or upper and lower limits
b Age in weeks estimated from weight post hoc if not reported
c Reported as 27–41 days
d Reported as 3 months
Study ID [reference] Animal  
intervention study
Random sequence  
allocation
n Gender/pig breed Weight  
(kg)a
Age in  
weeks
Boezaart [68] 1 group NA 10 Female/pigs 22–28 8–9b
Kajimoto et al. [82] 2 groups No 14 Male/yorkshire 7.8–14.5 4–6c
Lurie et al. [73] 2 groups Yes 22 Female/farm pigs 30.4 ± 1.3 9–11b
Navarro et al. [70] 1 group NA 6 Female/swine 21.5–92.8 8–21b
Silva et al. [71] 2 groups Yes 12 Male/large white 27.0 ± 3.6 12d
Silva et al. [67] 1 group NA 12 Male/Large white 26.2 ± 3.6 12d
Srinivasan et al. [72] 1 group NA 13 Female/domestic farm pigs 16–33 12–16
Yannopoulos et al. [100] 2 groups Yes 16 Female/farm pigs 30 ± 0.5 10–11b
Yannopoulos et al. [101] 2 groups No 12 Female/yorkshire-farm cross 31 ± 1.2 10–11b
Yannopoulos et al. [69] 2 groups Yes 16 Female/farm pigs 25.2 ± 2.1 8–9b
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studies while one study reported an rSO2 range from 65 
to 80 % (Table 7).
Evaluation of the effects of propofol and remifentanil
This systematic review was not able to identify studies 
with the primary objective to investigate the combined 
effects of propofol and remifentanil TIVA on cerebral 
perfusion and oxygenation in pigs. Thus, the question of 
how propofol and remifentanil affects CPO in healthy 
pigs remains uncertain. Silva et  al. [67] investigated the 
effect of a single high dose remifentanil bolus (5 µg/kg iv) 
on cerebral oxygenation during TIVA with propofol and 
remifentanil. They reported CPO outcome measures dur-
ing propofol-remifentanil infusion (Tables  5, 6, 7), that 
were within the normal target limits, while a single bolus 
of remifentanil significantly lowered cerebral oxygenation, 
yet still within normal limits (Table 1). Silva et al. [67] sug-
gest that this decrease may be associated with a decrease 
in cardiac output rather than altered cerebral metabolism. 
The primary aim of the remaining nine articles was not to 
Table 5 Means and 95 % confidence intervals of reported MAP
n: number of animals; MAP: mean arterial pressure; CI: confidence interval; LL: lower limit; UL: upper limit
a Calculated from systolic and diastolic blood pressure
Study ID [reference] n Outcome Measure Mean CI 95 % (LL) CI 95 % (UL)
Boezaart [68] 10 MAP mm Hg 89.0 82.6 95.4
Kajimoto et al. [82] 7 MAP mm Hg 69.0 63.1 74.9
Lurie et al. [73] 22 MAP mm Hg 91.8 85.3 98.2
Navarro et al. [70] 6 MAP mm Hg Range 70.0 110.0
Silva et al. [67] 12 MAP mm Hg 72.7 67.4 78.0
Silva et al. [71] 12 MAP mm Hg 73.0 67.3 78.7
Yannopoulos et al. [100] 16 MAP mm Hg 81.0 73.9 88.1
Yannopoulos et al. [101] 12 MAP mm Hg 90.0 81.2 98.8
Yannopoulos et al. [69] 16 MAPa mm Hg 90.1 83.8 96.4
Table 6 Means and 95 % confidence levels of reported cerebral perfusion measures
n: number of animals; CI: confidence interval; LL: lower limit; UL: upper limit; CBF: cerebral blood blow; CarotidBF: carotid blood flow; SvjO2: jugular venous 
haemoglobinoxygen saturation; CPP: cerebral perfusion pressure
Study ID [reference] n Outcome Measure Mean CI 95 % (LL) CI 95 % (UL)
Boezaart [68] 10 CBF TPU 44.7 29.2 60.2
Lurie et al. [73] 22 CarotidBF ml/min 119.4 101.8 136.9
Silva et al. [67] 12 SvjO2 % 82.7 77.0 88.3
Silva et al. [71] 12 SvjO2 % 79.0 73.9 84.1
Srinivasan et al. [72] 13 CPP mm Hg 73.6 67.0 80.2
Yannopoulos et al. [69] 16 CarotidBF ml/min 174.8 153.6 196.0
Yannopoulos et al. [100] 16 CPP mm Hg 68.0 61.6 74.4
Yannopoulos et al. [101] 12 CPP mm Hg 74.0 64.6 83.4
Yannopoulos et al. [69] 16 CPP mm Hg 74.8 67.2 82.3
Table 7 Means and 95 % confidence intervals of reported cerebral oxygenation measures
n: number of animals; CI: confidence interval; LL: lower limit; UL: upper limit; rSO2: regional cerebral oxygene saturation; brPO2: brain tissue partial pressure of oxygen
a Extrapolated from graph
Study ID [reference] n Outcome Measure Mean CI 95 % (LL) CI 95 % (UL)
Kajimoto et al. [82] 7 rSO2 % 51.0 47.1 54.9
Lurie et al. [73] 22 brPO2a mm Hg 13.2 9.9 16.5
Navarro et al. [70] 6 rSO2 % Range 65.0 80.0
Silva et al. [67] 12 rSO2 % 62.3 58.6 65.9
Silva et al. [71] 12 rSO2 % 65.0 61.6 68.4
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investigate the effects of propofol or propofol-remifent-
anil anaesthesia on CPO. Hence, data from these studies 
may have been influenced by factors other than anaesthe-
sia with propofol or remifentanil. Beydon et al. [74] who 
studied bispectral index stability in response to haemo-
dynamic instability, suggested that a propofol-remifent-
anil TIVA with a lower dose propofol (8.4 mg/kg/h) and 
a higher dose of remifentanil (0.54  µg/kg/min) provides 
a more stable anaesthetic depth compared to propo-
fol-remifentanil TIVA with a higher dose of propofol 
(26.7  mg/kg/h) and lower dose of remifentanil (0.34  µg/
kg/min). Relative to the findings made by Beydon et  al. 
[74], Boezaart et al. [68] used a very low dose of propofol 
for maintenance (3 mg/kg/h) and a low dose of remifenta-
nil, while the remainder of articles reviewed here, used a 
low–mid range propofol dose and a low remifentanil dose 
(Table 3). Silva et al. [71] defined a stable level of anaes-
thesia as total muscle relaxation, absence of palpebral 
reflex, and absence of hemodynamic response to interdig-
ital space clamping. Srinivasan et  al. [72] titrated anaes-
thesia on the basis of heart rate, blood pressure, tail and 
hoof response and spontaneous breathing. The depth of 
anaesthesia and consequently the stress response to sur-
gical stimulation thus may differ between studies, which 
makes comparison difficult. None of the studies however, 
reported concerns about insufficient anaesthetic depth.
Choice of model
The studies included used farm pigs of different breeds 
that were only specified in 4 of the studies (Table 4). Farm 
pig breeding standards vary from country to country 
resulting in pig breeds of varying anatomy and physiol-
ogy. When used in scientific studies thus, detailed consid-
eration should be given to the choice of pig breed [3, 75]. 
None of the studies reviewed here used mini or micro pig 
breeds but different farm pig breeds only, hence we find 
it acceptable to consider results as relatively comparable 
provided that age is taken into consideration. Based on 
the relationship between bodyweight and age, the animals 
included were approximately between 1 and 6  months 
old [64, 65]. For neurodevelopmental comparison to the 
human brain, it has been estimated that 1 week of life in 
the piglet approximates 1  month of life in humans [66]. 
Therefore, these animals could be considered equivalent 
to infants between 4 months and 2 years of age and may 
be the basis for a translational model of this paediatric 
subpopulation, while it seems less advisable to use this 
model in studies aiming at the human adult or geriat-
ric subpopulation [76]. Cerebral autoregulation has been 
shown to be impaired more extensively in newborn than 
in juvenile pigs in response to traumatic brain injury [4], 
which indicates an age-dependent maturation of the cer-
ebral autoregulatory response. Consequently, the youngest 
animals would be more sensitive to periods of hypotension 
(e.g. in response to anaesthetic induction) and potentially 
result in an over-interpretation of differing CPO responses 
between animals at both ends of the age span. This may 
explain the relatively broad range of rSO2 values in the 
study by Navarro et  al. [70], since this study was con-
ducted on few animals (n = 6) with body weights ranging 
from 21.5 to 92.8 kg and estimated ages of approximately 
8–21 weeks. In parallel, the relatively wide range in MAP 
observed may also be a result of an uneven sensitivity to 
the propofol doses between animals with different age. As 
a result, an inter-animal comparison could be biased due 
to unequal physiological prerequisites, even if cerebral 
oxygenation was still within target limits for pigs.
Gender has been described as a factor influencing 
cerebral autoregulation in piglets [77, 78]. None of the 
selected studies discussed the choice of animal gender.
Anaesthesia and drug contamination
Anaesthesia related discussion was brief and not given in 
all of the selected publications and main motivators for 
the choice of anaesthesia were animal welfare and anal-
gesia while less attention was given to the potential influ-
ence of anaesthesia on their main outcome measures. 
Premedication was an integrated part of the anaesthetic 
protocol in all 10 studies and might influence outcome 
data, possibly in a dose dependent manner. Ketamine, 
which was used in eight out of the ten studies included 
in this review, is recommended for premedication-
induction and reduction of stress response in pigs [39]. 
Ketamine has also been reported to increase CBF, ICP, 
and cerebral metabolic rate at high doses in pigs [40, 45, 
79–81]. None of the studies addressed the risk of drug 
contamination bias or length of washout periods, even 
though doses ≥30  mg/kg of ketamine were used for 
premedication in some of the studies [69, 72, 82]. How-
ever, from the trial descriptions we believe that the pre-
paratory periods were long enough to reduce the risk of 
drug contamination bias in the assessed studies [83]. If 
this also is the case for the two studies [70, 82] that com-
bined ketamine premedication with either xylazine alone 
or ketamine with tiletamine, zolazepam and xylazine, is 
unclear. However another α2-agonist, medetomidine, has 
been reported to have a more prolonged effect on heart 
rate in minipigs [84] and xylazine has been reported to 
reduce local cerebral CBF in rats [85]. Azaperone, which 
was used for sedation in two studies (Table 3) has been 
reported to influence both cerebral and systemic haemo-
dynamics, but is in general believed to have little influ-
ence on haemodynamics [86].
Boezaart [68] used pancuronium for muscle relaxation. 
High-dose pancuronium has been reported to widen the 
cerebral autoregulatory range in newborn piglets, but the 
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single bolus of 0.1 mg/kg, which was given at time of pre-
medication is not expected to have influenced cerebral 
haemodynamics [87].
In one survival study [69] the nonsteroidal anti-inflam-
matory drug flunixin was given for post-operative anal-
gesia intramuscularly, 1  h before surgical intervention. 
Flunixin has a relatively fast onset, and a long half-life of 
approximately 7  h in pigs [88]. The acute effect of flun-
ixin on the haemodynamics of the normal pig brain has 
not been investigated, but other cyclooxygenase inhibi-
tors have been reported to affect CBF when administered 
intravenously. Prostaglandin synthesis is cyclooxygenase 
dependent and plays a central role in maintaining CBF 
and cerebral autoregulation. It may be speculated that 
inhibition of prostaglandin synthesis by flunixin may 
influence CBF and consequently cerebral oxygenation 
[89]. The potential influence of flunixin on CPO assess-
ment was not discussed by Yannopoulos et al. [69].
Premedication, in terms of dose, time from admin-
istration to the beginning of CPO measurement, and 
expected serum concentration of drugs and active metab-
olites is relevant to assessing the risk of drug related out-
come contamination. Even though this is considered 
insignificant for primary outcome assessment, this was 
not addressed in any of the 10 articles reviewed.
Methods of CPO measurements
Monitoring CPO is a complex assessment of principally 
different variables such as systemic blood pressure, intra 
cranial pressure, tissue oxygen tension or haemoglobin 
saturation—all of which may be influenced by choice of 
monitoring technique [1, 20, 31, 90].
It is difficult to compare the cerebral perfusion meas-
ures reported in the selected articles. CBF was reported 
in 4 studies (Table 6). Lurie et al. [73] and Yannopoulos 
et al. [69] quantified a global measure of CBF by identi-
cal techniques of LDF over the exposed left common 
carotid artery. Lurie et  al. [73] reported significantly 
lower values than Yannopoulos et al. [69] despite similar 
animal weight, gender and anaesthetic protocols. Yanno-
poulos et al. [69] additionally used 2.2 mg/kg flunixin im 
prior to surgery, which would be expected to reveal the 
opposite relationship, since flunixin in theory may have 
a CBF lowering effect. However, wide carotid blood flow 
limits have been reported earlier. Boezaart [68] also used 
LDF, but measured CBF locally through a drilled crani-
otomy, and reported it as relative tissue perfusion units, 
where the other studies reported it as absolute ml/min. 
Comparison of the CBF from the three studies is difficult 
because of the difference in measuring techniques, brain 
area of interest and wide normal flow limits [32, 91].
CPP was reported in four studies with a range between 
68 and 74.8  mmHg, which is similar to previously 
reported CPP in healthy pigs anaesthetized with mida-
zolam and fentanyl after ketamine and xylazine seda-
tion [34]. More studies are required to verify this, and to 
determine a more exact range for CPP in pigs during dif-
ferent types of anaesthesia. Collectively however, none of 
the reported cerebral perfusion measures (Table 6) were 
outside the normal ranges for humans that are available 
in the literature (Table 1).
Cerebral oxygenation is a measure of oxygen available 
for consumption and energy metabolism in the brain. 
Lurie et al. [73] reported a mean brPO2 baseline value of 
13.2 mm Hg, 95 % CI [9.9–16.5 mm Hg]. This brPO2 is 
well outside the target ranges available in healthy swine 
of 25–30  mm  Hg [35] and further, is within the ischae-
mic range of <15  mm  Hg in humans [1, 22, 92]. Lurie 
et  al. [73] used the baseline as a relative comparison to 
post-interventional measures, however the relatively low 
brPO2 is not discussed in the article.
Non-invasive measurement of rSO2 with near infra-
red spectroscopy was performed in 4 studies and base-
line values were reported for both propofol studies and 
for propofol and remifentanil studies (Table 7). Navarro 
et al. [70] reported an rSO2 range between 65 and 80 % 
with the upper range slightly above the target range of 
57–72 % [36]. Kajimoto et al. [82] reported an rSO2 mean 
of 51  %, 95  % CI (47.1; 54.9). This lower oxygenation 
measure could be related to the use of younger animals in 
this study and the high-dose ketamine and xylazine in the 
premedication used in this experiment. The earlier stage 
of neurodevelopment could render the animals more sus-
ceptible to sedative agents, which would lead to a more 
extensive metabolic cerebral depression and therefore 
lower oxygen demand.
Conclusions
Even though the very limited pool of evidence reviewed 
here, it suggests that propofol and remifentanil alone or 
in combination have limited effects on CPO in healthy 
pigs, confirmative evidence is lacking. In one study base-
line CPO measures were within normal target ranges in 
healthy pigs during propofol-remifentanil TIVA. Addi-
tion of a single remifentanil dose significantly reduced 
rSO2 but not beyond normal target ranges.
There is a need for standardised porcine studies with 
the primary objective of studying the influence of anaes-
thetic drugs on CPO in non-diseased animals.
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